
Shantakaram Pharmaceuticals Private Limited
About Shantakaram Pharmaceuticals Private Limited
Data last updated:
Shantakaram Pharmaceuticals Private Limited is a private limited company based in Gwalior, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2021PTC057408. Its GSTIN is 07ABGCS8628A1ZC (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Aditya Chhaparwal and Rohan Parecha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1468 C/O Anand Mohan Chhaparwal Daulatganj Lashkar, Gwalior, Madhya Pradesh, India – 474001.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.02 Lakh, a decline of 66% compared to the previous year. For the same year it recorded a net profit of ₹2.02 Lakh (net margin 12.6%) and EBITDA of ₹2.02 Lakh (EBITDA margin 12.6%).
Company details
Recognitions & Rankings of Shantakaram Pharmaceuticals
Contact details
Shantakaram Pharmaceuticals Private Limited's registered office is in Gwalior, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address1468 C/O Anand Mohan Chhaparwal Daulatganj Lashkar, Gwalior, Madhya Pradesh, India – 474001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Shantakaram Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shantakaram Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Shantakaram Pharmaceuticals Private Limited, buy the company report.
Financials of Shantakaram Pharmaceuticals Private Limited
FY 2025 filings availableShantakaram Pharmaceuticals Private Limited reported revenue of ₹16.02 Lakh (down 66% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 66% in the latest year. EBITDA rose 114% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.02 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹2.02 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 12.6% | ||
| Net Profit Margin | 12.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Shantakaram Pharmaceuticals Private Limited, buy the company report.
Board of directors of Shantakaram Pharmaceuticals Private Limited
Shantakaram Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Chhaparwal Also directs: Dindayal Real Estate LLP, Dindayal Industries Limited, Dindayal Enterprises Pvt Ltd and 1 more | Director | 09 Sep 2021 | 5 Years 2 Months | Current |
| Rohan Parecha Also directs: Rishabh Grit Industry LLP | Director | 22 Jul 2022 | 4 Years 3 Months | Current |
Peer comparison
Shantakaram Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Morris Mark Pharmaceuticals Private Limited | ₹16.08 Lakh (FY 2025) | 60.0% | Wayanad, Kerala, India | |||
| Shantakaram Pharmaceuticals Private Limitedthis company | ₹16.02 Lakh (FY 2024) | ₹2.02 Lakh | 12.6% | -66.0% | Gwalior, Madhya Pradesh, India | |
| Sugam Pharmaceuticals Private Limited | ₹16 Lakh (FY 2025) | -2.0% | Muktsar, Punjab, India | |||
| Astrobio Pharmaceuticals Private Limited | ₹15.98 Lakh (FY 2025) | 66.0% | Pune, Maharashtra, India |
To see the full peer comparison of Shantakaram Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shantakaram Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shantakaram Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Shantakaram Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 16, 2026.
GST
Shantakaram Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABGCS8628A1ZC | Delhi | Active | 25 Aug 2022 |
To see the full GST registrations and return filing status of Shantakaram Pharmaceuticals Private Limited, buy the company report.
Recent activity
Shantakaram Pharmaceuticals Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Anand Mohan Chhaparwal ceased to be Director on 22 Jul 2022.
Frequently asked questions
Shantakaram Pharmaceuticals is an active private limited company based in Gwalior, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 September 2021 (5+ years old) and is registered under CIN U24230MP2021PTC057408.
Shantakaram Pharmaceuticals has 2 current directors:
- Aditya Chhaparwal - Director
- Rohan Parecha - Director
The latest financial statements of Shantakaram Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Shantakaram Pharmaceuticals is 07ABGCS8628A1ZC, registered in Delhi.
The CIN (Corporate Identification Number) of Shantakaram Pharmaceuticals is U24230MP2021PTC057408. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shantakaram Pharmaceuticals was incorporated on 09 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Shantakaram Pharmaceuticals by revenue are Morris Mark Pharmaceuticals Private Limited, Sugam Pharmaceuticals Private Limited, Astrobio Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anand Mohan Chhaparwal ceased to be Director on 22 Jul 2022. Rohan Parecha was appointed as Director on 22 Jul 2022. Aditya Chhaparwal was appointed as Director on 09 Sep 2021.
Yes, Shantakaram Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Shantakaram Pharmaceuticals is at 1468 CO Anand Mohan Chhaparwal Daulatganj Lashkar, Gwalior, Madhya Pradesh, India – 474001.
Shantakaram Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

